Tim E. Taber

1.2k total citations
62 papers, 755 citations indexed

About

Tim E. Taber is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Tim E. Taber has authored 62 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Transplantation, 29 papers in Surgery and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Tim E. Taber's work include Renal Transplantation Outcomes and Treatments (31 papers), Organ Transplantation Techniques and Outcomes (21 papers) and Organ Donation and Transplantation (17 papers). Tim E. Taber is often cited by papers focused on Renal Transplantation Outcomes and Treatments (31 papers), Organ Transplantation Techniques and Outcomes (21 papers) and Organ Donation and Transplantation (17 papers). Tim E. Taber collaborates with scholars based in United States, Switzerland and United Kingdom. Tim E. Taber's co-authors include John A. Powelson, Jonathan A. Fridell, Muhammad A. Mujtaba, Richard S. Mangus, Asif Sharfuddin, Muhammad S. Yaqub, William C. Goggins, Andrew L. Lobashevsky, Karen O. Ehrman and Martin L. Milgrom and has published in prestigious journals such as American Journal of Kidney Diseases, Transplantation and American Journal of Transplantation.

In The Last Decade

Tim E. Taber

58 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim E. Taber United States 18 429 423 175 158 116 62 755
David B. Leeser United States 20 461 1.1× 388 0.9× 416 2.4× 258 1.6× 82 0.7× 56 900
Anil Paramesh United States 14 483 1.1× 275 0.7× 153 0.9× 187 1.2× 80 0.7× 71 800
Núria Montero Spain 16 242 0.6× 363 0.9× 105 0.6× 68 0.4× 110 0.9× 58 708
Brenda Muth United States 19 484 1.1× 777 1.8× 218 1.2× 112 0.7× 304 2.6× 44 1.0k
Zubir Ahmed United Kingdom 12 265 0.6× 108 0.3× 85 0.5× 205 1.3× 40 0.3× 21 473
Robert L. Madden United States 13 245 0.6× 133 0.3× 52 0.3× 150 0.9× 95 0.8× 24 459
D Anaise United States 11 247 0.6× 121 0.3× 109 0.6× 191 1.2× 62 0.5× 58 531
Julianne E. Burns United States 10 232 0.5× 120 0.3× 84 0.5× 216 1.4× 98 0.8× 17 536
P Szyber Poland 12 189 0.4× 242 0.6× 52 0.3× 82 0.5× 81 0.7× 46 426
İbrahim Berber Türkiye 16 319 0.7× 103 0.2× 121 0.7× 212 1.3× 67 0.6× 58 591

Countries citing papers authored by Tim E. Taber

Since Specialization
Citations

This map shows the geographic impact of Tim E. Taber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim E. Taber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim E. Taber more than expected).

Fields of papers citing papers by Tim E. Taber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim E. Taber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim E. Taber. The network helps show where Tim E. Taber may publish in the future.

Co-authorship network of co-authors of Tim E. Taber

This figure shows the co-authorship network connecting the top 25 collaborators of Tim E. Taber. A scholar is included among the top collaborators of Tim E. Taber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim E. Taber. Tim E. Taber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Sayegh, Suzanne, et al.. (2021). Bamlanivimab for COVID-19 in kidney transplant patients. American Journal of Transplantation. 21. 861–862. 1 indexed citations
2.
Sharfuddin, Asif, Muhammad A. Mujtaba, Chandru P. Sundaram, et al.. (2021). Living Donor Gifted Lithiasis: Long-Term Outcomes in Recipients. Transplantation Proceedings. 53(3). 1091–1094. 3 indexed citations
3.
Yaqub, Muhammad S., et al.. (2019). Late pancreatic panniculitis in a simultaneous pancreas kidney transplant patient with failed allografts. American Journal of Transplantation. 19(10). 2934–2938. 1 indexed citations
4.
Paramesh, Anil, Nikole Neidlinger, Marco Salvatore, et al.. (2017). OPO Strategies to Prevent Unintended Use of Kidneys Exported for High PRA (>98% cPRA) Recipients. American Journal of Transplantation. 17(8). 2139–2143. 9 indexed citations
5.
6.
Mujtaba, Muhammad A., Wendy Komocsar, Millie Samaniego, et al.. (2016). Effect of Treatment With Tabalumab, a B Cell–Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation. American Journal of Transplantation. 16(4). 1266–1275. 27 indexed citations
7.
Nagai, Shunji, et al.. (2015). Allograft Pancreatectomy: Indications and Outcomes. American Journal of Transplantation. 15(9). 2456–2464. 17 indexed citations
8.
Ekser, Burcin, Richard S. Mangus, John A. Powelson, et al.. (2015). Impact of duration of diabetes on outcome following pancreas transplantation. International Journal of Surgery. 18. 21–27. 3 indexed citations
9.
Mujtaba, Muhammad A., et al.. (2014). Conversion From Tacrolimus to Belatacept to Prevent the Progression of Chronic Kidney Disease in Pancreas Transplantation: Case Report of Two Patients. American Journal of Transplantation. 14(11). 2657–2661. 19 indexed citations
10.
11.
Kandula, Praveen, Jonathan A. Fridell, Tim E. Taber, et al.. (2012). Impact of Tacrolimus-Sirolimus Maintenance Immunosuppression on Proteinuria and Kidney Function in Pancreas Transplant Alone Recipients. Transplantation. 94(9). 940–946. 19 indexed citations
12.
Powelson, John A., et al.. (2011). Pancreas transplantation after bariatric surgery. Clinical Transplantation. 26(1). E1–6. 17 indexed citations
13.
Mujtaba, Muhammad A., William C. Goggins, Andrew L. Lobashevsky, et al.. (2010). The strength of donor-specific antibody is a more reliable predictor of antibody-mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients. Clinical Transplantation. 25(1). E96–E102. 20 indexed citations
14.
15.
Mujtaba, Muhammad A., Tim E. Taber, William C. Goggins, et al.. (2010). Early Steroid Withdrawal in Repeat Kidney Transplantation. Clinical Journal of the American Society of Nephrology. 6(2). 404–411. 13 indexed citations
16.
Fridell, Jonathan A., Richard S. Mangus, Edward F. Hollinger, et al.. (2009). No Difference in Transplant Outcomes for Local and Import Pancreas Allografts. Transplantation. 88(5). 723–728. 22 indexed citations
17.
Fridell, Jonathan A., Richard S. Mangus, Edward F. Hollinger, et al.. (2009). The case for pancreas after kidney transplantation. Clinical Transplantation. 23(4). 447–453. 41 indexed citations
18.
Contreras, Gabriel, Lawrence W. Elzinga, Michael S. Anger, et al.. (2003). A multicenter, prospective, randomized, comparative evaluation of dual- versus triple-lumen catheters for hemodialysis and apheresis in 485 patients. American Journal of Kidney Diseases. 42(2). 315–324. 15 indexed citations
19.
Ehrman, Karen O., et al.. (1994). Comparison of Diagnostic Accuracy with Carbon Dioxide versus Iodinated Contrast Material in the Imaging of Hemodialysis Access Fistulas. Journal of Vascular and Interventional Radiology. 5(5). 771–775. 59 indexed citations
20.
Taber, Tim E., et al.. (1987). Treatment of iron overload in continuous ambulatory peritoneal dialysis patients.. PubMed. 33(3). 654–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David B. Leeser Breakdown of academic impact, for papers by Anil Paramesh Breakdown of academic impact, for papers by Núria Montero Breakdown of academic impact, for papers by Brenda Muth Breakdown of academic impact, for papers by Zubir Ahmed Breakdown of academic impact, for papers by Robert L. Madden Breakdown of academic impact, for papers by D Anaise Breakdown of academic impact, for papers by Julianne E. Burns Breakdown of academic impact, for papers by P Szyber Breakdown of academic impact, for papers by İbrahim Berber
Rankless by CCL
2026